VERTEX PHARMACEUTICALS INC / MA Insider Trading for November 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for November 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 224.44 | 8 | 1,796 | 35,103 | 35.1 K to 35.1 K (-0.02 %) |
| Nov 18 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 223.76 | 22 | 4,923 | 35,111 | 35.1 K to 35.1 K (-0.06 %) |
| Nov 18 2020 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Chief Patient ... | Sell | S | 222.50 | 12 | 2,670 | 35,133 | 35.1 K to 35.1 K (-0.03 %) |
| Nov 18 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 224.34 | 25 | 5,609 | 26,838 | 26.9 K to 26.8 K (-0.09 %) |
| Nov 18 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 223.67 | 40 | 8,947 | 26,863 | 26.9 K to 26.9 K (-0.15 %) |
| Nov 18 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 222.52 | 26 | 5,786 | 26,903 | 26.9 K to 26.9 K (-0.10 %) |
| Nov 18 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 224.11 | 5 | 1,121 | 35,179 | 35.2 K to 35.2 K (-0.01 %) |
| Nov 18 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 222.47 | 2 | 445 | 35,184 | 35.2 K to 35.2 K (-0.01 %) |
| Nov 18 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 224.32 | 10 | 2,243 | 28,902 | 28.9 K to 28.9 K (-0.03 %) |
| Nov 18 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 223.57 | 18 | 4,024 | 28,912 | 28.9 K to 28.9 K (-0.06 %) |
| Nov 18 2020 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Sell | S | 222.45 | 10 | 2,225 | 28,930 | 28.9 K to 28.9 K (-0.03 %) |
| Nov 12 2020 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Buy | P | 218.79 | 3,905 | 854,375 | 26,210 | 22.3 K to 26.2 K (+17.51 %) |
| Nov 12 2020 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Buy | P | 217.49 | 4,270 | 928,682 | 22,305 | 18 K to 22.3 K (+23.68 %) |
| Nov 12 2020 | VRTX | VERTEX PHARMACEUTI ... | SACHS BRUCE I | Director | Buy | P | 216.47 | 6,825 | 1,477,408 | 18,035 | 11.2 K to 18 K (+60.88 %) |
| Nov 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Option Exercise | M | 86.52 | 2,330 | 201,592 | 2,330 | |
| Nov 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 221.25 | 200 | 44,250 | 26,838 | 27 K to 26.8 K (-0.74 %) |
| Nov 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 220.10 | 300 | 66,030 | 27,038 | 27.3 K to 27 K (-1.10 %) |
| Nov 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 218.63 | 600 | 131,178 | 27,338 | 27.9 K to 27.3 K (-2.15 %) |
| Nov 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 217.20 | 600 | 130,320 | 27,938 | 28.5 K to 27.9 K (-2.10 %) |
| Nov 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Sell | S | 215.16 | 630 | 135,551 | 28,538 | 29.2 K to 28.5 K (-2.16 %) |
| Nov 06 2020 | VRTX | VERTEX PHARMACEUTI ... | Parini Michael | EVP, Chief Adm, Leg ... | Buy | M | 86.52 | 2,330 | 201,592 | 29,168 | 26.8 K to 29.2 K (+8.68 %) |
| Nov 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Option Exercise | M | 86.52 | 1,553 | 134,366 | 1,554 | |
| Nov 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 214.13 | 334 | 71,519 | 35,179 | 35.5 K to 35.2 K (-0.94 %) |
| Nov 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 212.38 | 245 | 52,033 | 35,513 | 35.8 K to 35.5 K (-0.69 %) |
| Nov 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 211.54 | 487 | 103,020 | 35,758 | 36.2 K to 35.8 K (-1.34 %) |
| Nov 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Sell | S | 210.56 | 487 | 102,543 | 36,245 | 36.7 K to 36.2 K (-1.33 %) |
| Nov 05 2020 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP, Chief Commerci ... | Buy | M | 86.52 | 1,553 | 134,366 | 36,732 | 35.2 K to 36.7 K (+4.41 %) |